The U.S. Food and Drug Administration said a comprehensive review “found no increased” risk related to suicide among users of ...
Oprah Winfrey says she had one big main side effect from taking a GLP-1 weight-loss drug. The most common problems for ...
SAN FRANCISCO, Jan 12 () - Amgen's research chief said the company is very confident about its experimental obesity drug ...
An extension study of Amgen's experimental obesity drug MariTide found that it helped people maintain weight loss while a ...
Many low-income Californians prescribed wildly popular weight loss drugs lost their coverage for the medications at the start ...
Combination therapy with ixekizumab and tirzepatide bested monotherapy with ixekizumab alone in both psoriatic arthritis and ...
Learn how GLP-1 medications support weight loss and heart health in perimenopause and postmenopause, plus get tips for ...
Low-income Californians who use GLP-1s for weight loss lost their coverage at the start of the new year, with officials advising diet and exercise instead.
Eli Lilly’s research and development head said on Monday the company will have plenty of supply to launch its ...
While GLP-1s boast impressive weight loss results, making one mistake could result in the pounds coming right back on, ...
What started out as a medication for diabetes and weight loss is offering something quite unexpected for many women. Experts ...
Discontinuing obesity medicines often means the weight comes back and people lose the cardiovascular and metabolic benefits ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results